UnityPoint Health Ventures

UnityPoint Health Ventures, established in 2019, serves as the corporate venture capital arm of UnityPoint Health, headquartered in West Des Moines, Iowa. The organization focuses on investing in early-stage companies within the healthcare sector, including areas such as digital therapeutics, health information technology, tech-enabled services, medical devices, and diagnostics. UnityPoint Health Ventures is dedicated to fostering innovation that enhances the patient and provider experience, seeking partnerships that align with its mission to improve healthcare delivery and accessibility.

Austin Duke

Senior Venture Associate

Matthew Warrens

Managing Director

16 past transactions

TailorMed

Series B in 2024
TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data set to create actionable insights.

OpenLoop Health

Series A in 2023
OpenLoop Health is a technology company that provides a comprehensive infrastructure for digital healthcare, enabling healthcare organizations to enhance their service delivery. The company offers a full-stack platform that simplifies telehealth by centralizing essential services, including clinician support, laboratory services, medication management, and regulatory compliance. OpenLoop's solutions are designed to assist healthcare companies in scaling their virtual care services effectively, addressing staff shortages by maintaining an updated provider database and facilitating job matching based on location and specialty. This streamlined approach supports healthcare institutions in efficiently meeting their staffing needs while ensuring high-quality patient care.

Cardiosense

Series A in 2022
Cardiosense develops a physiological waveform AI platform aimed at creating predictive biomarkers for the detection and treatment of cardiac diseases. The company utilizes raw biosignals and advanced signal processing techniques to gain insights into cardiac functions and identify pre-symptomatic markers of cardiac conditions. By leveraging multi-sensor devices and proprietary algorithms, Cardiosense focuses on non-invasive monitoring solutions that enhance healthcare professionals' ability to analyze cardiac health data and track patient well-being. This innovative approach facilitates early detection of diseases, ultimately aiming to improve patient outcomes in cardiac care.

Pathware

Series A in 2022
Pathware Inc. specializes in developing automated point-of-care biopsy assessment systems aimed at enhancing the diagnostic capabilities of clinicians and pathologists. Its flagship product, Bioptic, allows for the rapid diagnosis of pathogens, while its sample management platform streamlines the pathology workflow by minimizing repetitive tasks. The company’s digital pathology platform integrates advanced hardware and software tools, facilitating immediate analysis of tissue samples at the point of care, thereby reducing the need to send samples to central laboratories. This innovation significantly shortens turnaround times and improves patient care through AI-powered image analysis and telepathology capabilities. Founded in 2017 and headquartered in Ann Arbor, Michigan, with an additional location in Seattle, Washington, Pathware is dedicated to improving healthcare by leveraging computational microscopy and artificial intelligence for more accurate and timely disease diagnosis and treatment.

Prolucent

Series A in 2021
Prolucent Health specializes in technology and services aimed at optimizing healthcare workforce management. The company offers a platform that leverages artificial intelligence and advanced analytics to address labor needs through data-driven decision-making. By modernizing recruitment and improving the utilization and cost of healthcare labor, Prolucent enables employers to effectively manage both full-time and contingent workforce components. Additionally, the platform engages healthcare workers, helping them discover suitable job opportunities.

b.well Connected Health

Series B in 2021
b.well Connected Health, Inc. is a healthcare technology company based in Baltimore, Maryland, with an additional location in Austin, Texas. Founded in 2015, the company has developed a healthcare application that consolidates and analyzes a consumer's healthcare data. This platform enables users to manage and share medical records and family health history while providing insights into financial aspects of their healthcare, such as benefit plans, co-pays, and deductibles. Additionally, it integrates data from wearables and self-reported sources to track various health metrics, including sleep, fitness, and nutrition. By offering an integrated solution tailored for health plans, health systems, employers, and pharmaceutical companies, b.well Connected Health seeks to empower individuals to optimize their healthcare experience and promote holistic health management.

TailorMed

Venture Round in 2021
TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data set to create actionable insights.

DocStation

Seed Round in 2021
DocStation, Inc. is a cloud-based patient care platform designed for pharmacists, incorporated in 2017 and headquartered in Austin, Texas. The platform connects payers and pharmacists to facilitate value-based programs, aiming to reduce healthcare costs while enhancing patient outcomes. With over 500 providers collaborating with innovative health plans, DocStation equips pharmacists with tools that streamline patient management. Its comprehensive dashboard allows for the maintenance of current diagnoses, medications, immunizations, and allergies, while also facilitating the creation of care plans, monitoring adherence, and scheduling follow-ups. By enabling real-time connections between pharmacists and patients, DocStation supports a shift towards value-based care in the pharmacy sector.

SilverCloud Health

Series B in 2020
SilverCloud Health, founded in 2011 and based in Boston, Massachusetts, specializes in providing evidence-based digital therapies aimed at improving mental wellness. The company offers tailored online therapeutic solutions that address various mental health issues, enhancing overall emotional health. SilverCloud's platform has demonstrated significant success, achieving a three-fold increase in client engagement and a three-fold decrease in program dropout rates compared to leading online therapeutic products. By providing affordable and accessible digital health resources, SilverCloud Health aims to empower users to manage their mental health more effectively.

Bright.md

Series C in 2020
Bright.md Inc. is a healthcare technology company based in Portland, Oregon, specializing in software solutions for the diagnosis and treatment of low-acuity conditions. The company offers SmartExam, an AI-driven online care platform that enhances telehealth services for healthcare systems. SmartExam connects patients with physicians to address common health concerns through an asynchronous process, allowing individuals to receive high-quality care from trusted providers via their computers or mobile devices. By partnering with leading healthcare organizations, Bright.md serves over 10 million patients, streamlining access to urgent and primary care while reducing the need for in-person visits. Founded in 2012, Bright.md aims to modernize the patient experience by providing a virtual front door for healthcare services.

VIDA

Series C in 2020
VIDA is a lung health company focused on modernizing respiratory care through artificial intelligence and advanced data analytics. It empowers healthcare organizations and physicians to enhance patient outcomes, improve care coordination, and drive efficiencies. VIDA's comprehensive software solutions, which are FDA cleared and CE-marked, assist in managing patients with chronic obstructive pulmonary disease, interstitial lung disease, lung cancer, and COVID-19. The company also provides a full suite of clinical trial services, including advanced quantitative image analysis, to strengthen trial data and site quality, as well as subject screening. With a commitment to proven quality and clinical leadership, VIDA aims to accelerate the delivery of new therapies to patients.

b.well Connected Health

Series A in 2020
b.well Connected Health, Inc. is a healthcare technology company based in Baltimore, Maryland, with an additional location in Austin, Texas. Founded in 2015, the company has developed a healthcare application that consolidates and analyzes a consumer's healthcare data. This platform enables users to manage and share medical records and family health history while providing insights into financial aspects of their healthcare, such as benefit plans, co-pays, and deductibles. Additionally, it integrates data from wearables and self-reported sources to track various health metrics, including sleep, fitness, and nutrition. By offering an integrated solution tailored for health plans, health systems, employers, and pharmaceutical companies, b.well Connected Health seeks to empower individuals to optimize their healthcare experience and promote holistic health management.

CareSignal

Venture Round in 2020
CareSignal is a provider of a remote patient monitoring platform designed to enhance the performance of payers and providers in value-based care. The platform engages large patient populations through disease-specific, evidence-based automated communications via text messages and phone calls. By identifying rising-risk patients, CareSignal enables care teams to receive real-time alerts, allowing for timely prioritization and outreach. This approach helps address the needs of underserved populations and their safety-net providers, as patients can utilize their existing phones to interact with the system. Ultimately, CareSignal aims to facilitate proactive care for individuals facing chronic, behavioral, and social challenges.

Kaizen Health

Series B in 2020
Kaizen Health, Inc. is a healthcare mobility company based in Chicago, Illinois, founded in 2015. It operates a web-based platform that connects healthcare providers with transportation services, aiming to eliminate transportation barriers that hinder access to medical care. By facilitating rides for patients, the company serves various sectors, including healthcare systems, pharmaceutical companies, payers, in-home healthcare, and senior living. Kaizen Health's technology and transportation network are designed to enhance access, quality, satisfaction, and efficiency in healthcare delivery, particularly for vulnerable populations such as low-income individuals, the elderly, the disabled, and veterans. The platform also addresses social determinants of health and promotes health equity by ensuring that patients receive timely communication about their appointments and transportation arrangements.

CareSignal

Seed Round in 2019
CareSignal is a provider of a remote patient monitoring platform designed to enhance the performance of payers and providers in value-based care. The platform engages large patient populations through disease-specific, evidence-based automated communications via text messages and phone calls. By identifying rising-risk patients, CareSignal enables care teams to receive real-time alerts, allowing for timely prioritization and outreach. This approach helps address the needs of underserved populations and their safety-net providers, as patients can utilize their existing phones to interact with the system. Ultimately, CareSignal aims to facilitate proactive care for individuals facing chronic, behavioral, and social challenges.

VIDA

Corporate Round in 2019
VIDA is a lung health company focused on modernizing respiratory care through artificial intelligence and advanced data analytics. It empowers healthcare organizations and physicians to enhance patient outcomes, improve care coordination, and drive efficiencies. VIDA's comprehensive software solutions, which are FDA cleared and CE-marked, assist in managing patients with chronic obstructive pulmonary disease, interstitial lung disease, lung cancer, and COVID-19. The company also provides a full suite of clinical trial services, including advanced quantitative image analysis, to strengthen trial data and site quality, as well as subject screening. With a commitment to proven quality and clinical leadership, VIDA aims to accelerate the delivery of new therapies to patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.